{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:23:48Z","timestamp":1783639428151,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.clnu.2014.09.007","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T20:12:56Z","timestamp":1411071176000},"page":"874-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Relationship between TG\/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population"],"prefix":"10.1016","volume":"34","author":[{"given":"Chih-I.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jau-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Yen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chung","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2014.09.007_bib1","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data","volume":"367","author":"Lopez","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2014.09.007_bib2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2014.09.007_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.ajkd.2006.10.007","article-title":"Epidemiological features of CKD in Taiwan","volume":"49","author":"Kuo","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clnu.2014.09.007_bib4","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(08)60952-6","article-title":"All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan","volume":"371","author":"Wen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2014.09.007_bib5","series-title":"US renal data system, USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States","author":"Bethesda","year":"2012"},{"key":"10.1016\/j.clnu.2014.09.007_bib6","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00467-007-0467-5","article-title":"Lipoprotein metabolism in chronic renal insufficiency","volume":"22","author":"Saland","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clnu.2014.09.007_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.amjcard.2007.09.109","article-title":"Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham offspring cohort)","volume":"101","author":"Kannel","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clnu.2014.09.007_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2337\/dc11-1456","article-title":"Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children","volume":"35","author":"Di Bonito","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2014.09.007_bib9","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2337\/dc07-0512","article-title":"Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults","volume":"30","author":"Sung","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2014.09.007_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1464-5491.2011.03420.x","article-title":"Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands","volume":"29","author":"de Leon","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.clnu.2014.09.007_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.numecd.2008.09.003","article-title":"Triglyceride\/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men","volume":"19","author":"Hadaegh","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2014.09.007_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2008.11.014","article-title":"The triglyceride\/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the women's ischemia syndrome evaluation (WISE)","volume":"157","author":"Bittner","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.clnu.2014.09.007_bib13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","article-title":"The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))","volume":"34","author":"Dobiasova","year":"2001","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clnu.2014.09.007_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000323895","article-title":"Association between the ratio of triglycerides to high-density lipoprotein cholesterol and chronic kidney disease in Korean adults: the 2005 Korean National Health and Nutrition Examination Survey","volume":"34","author":"Kang","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.clnu.2014.09.007_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2010.04.035","article-title":"Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction","volume":"212","author":"Zoppini","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnu.2014.09.007_bib16","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.293.14.1737","article-title":"Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors","volume":"293","author":"Shlipak","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2014.09.007_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2215\/CJN.03390807","article-title":"Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis","volume":"3","author":"de Boer","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.clnu.2014.09.007_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MAJ.0b013e3181a92804","article-title":"Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults","volume":"338","author":"Lee","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clnu.2014.09.007_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","article-title":"Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?","volume":"96","author":"McLaughlin","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clnu.2014.09.007_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00494.x","article-title":"Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations","volume":"231","author":"Laws","year":"1992","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.clnu.2014.09.007_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2840-7-4","article-title":"Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race\/ethnicity?","volume":"7","author":"Li","year":"2008","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.clnu.2014.09.007_bib22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.amjcard.2012.02.016","article-title":"Relation among the plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women","volume":"109","author":"Salazar","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clnu.2014.09.007_bib23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jacl.2012.05.002","article-title":"Prevalence of lipid abnormalities in the United States: the national health and nutrition examination survey 2003\u20132006","volume":"6","author":"Toth","year":"2012","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.clnu.2014.09.007_bib24","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1681\/ASN.2006040368","article-title":"Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease","volume":"17","author":"Ma","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clnu.2014.09.007_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2014.09.007_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.ki.5002128","article-title":"The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort","volume":"71","author":"Kitiyakara","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnu.2014.09.007_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-140-3-200402030-00007","article-title":"The metabolic syndrome and chronic kidney disease in U.S. adults","volume":"140","author":"Chen","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2014.09.007_bib28","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1681\/ASN.2005010106","article-title":"Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults","volume":"16","author":"Kurella","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clnu.2014.09.007_bib29","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clnu.2014.09.007_bib30","first-page":"33","article-title":"Interstitial foam cells and oxidized lipoprotein in human glomerular disease","volume":"12","author":"Magil","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clnu.2014.09.007_bib31","first-page":"149","article-title":"Interactions between lipoproteins, glomerular cells and matrix","volume":"19","author":"Wheeler","year":"1993","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.clnu.2014.09.007_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.1993.35","article-title":"LDL stimulates mesangial fibronectin production and chemoattractant expression","volume":"43","author":"Rovin","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnu.2014.09.007_bib33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2014.09.007_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00394-011-0286-0","article-title":"Waist-to-height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults","volume":"52","author":"Li","year":"2013","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnu.2014.09.007_bib35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diabres.2012.12.013","article-title":"Waist to height ratio: a better anthropometric marker of diabetes and cardio-metabolic risks in South Asian adults","volume":"99","author":"Jayawardana","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clnu.2014.09.007_bib36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clnu.2014.09.007_bib37","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1681\/ASN.2004110919","article-title":"Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations","volume":"16","author":"Pohl","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clnu.2014.09.007_bib38","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1046\/j.1523-1755.1999.07125.x","article-title":"Progression of diabetic nephropathy in normotensive type 1 diabetic patients","volume":"71","author":"Jacobsen","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clnu.2014.09.007_bib39","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198806233182505","article-title":"The progression of renal disease","volume":"318","author":"Klahr","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2014.09.007_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00041552-200201000-00011","article-title":"Long-term renal consequences of hypertension for normal and diseased kidneys","volume":"11","author":"Bidani","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.clnu.2014.09.007_bib41","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1046\/j.1523-1755.2000.00045.x","article-title":"Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria","volume":"57","author":"Hebert","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.clnu.2014.09.007_bib42","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1681\/ASN.2005121319","article-title":"Importance of blood pressure control in chronic kidney disease","volume":"17","author":"Ravera","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.clnu.2014.09.007_bib43","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2007.02.259","article-title":"Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan","volume":"49","author":"Guh","year":"2007","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561414002350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561414002350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T16:53:11Z","timestamp":1538239991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561414002350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0261561414002350"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2014.09.007","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between TG\/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2014.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}